Creating Health-Enabling Supermarkets in Australia: Using the Store Scout App in Health Promotion Practice
Health Promot J Austr. 2026 Jan;37(1):e70147. doi: 10.1002/hpja.70147. ABSTRACT INTRODUCTION: Food retail outlets represent a setting where a healthy diet can be promoted. Community public health practitioners need user-friendly tools to collect real-time data, engage with local food retailers, and customise health-enabling initiatives in supermarkets. We aimed to examine the distribution and variation of Store […]
Construction of a mobile health technology-based early identification model for postpartum depression and evaluation of its application effects in community postpartum visits
Afr J Reprod Health. 2025 Dec 23;29(12):87-103. doi: 10.29063/ajrh2025/v29i12.9. ABSTRACT This study developed a mobile health-based early identification model for postpartum depression (PPD) and evaluated its effectiveness in community postpartum visits. A randomized controlled trial included 102 postpartum women (intervention: n=54; control: n=48). The intervention group used the “Maternal Love Guardian” app, integrating clinical risk […]
The Surprising Brain Effects of Stimulants: Reward Over Attention
Commonly prescribed stimulants include methylphenidate and lisdexamfetamine, which are effective drugs that improve the level of wakefulness and energy by increasing the levels of dopamine and norepinephrine in the brain. The prevalence of the medication is 6.1% among all Americans and as high as 24.6% among boys aged 10–19 years. Stimulants are primarily prescribed for […]
What Happens When You’re Just Mind Blanking
William James described consciousness as a dynamic and continuous stream. During wakefulness, experience usually feels unbroken. Research shows that attention frequently fluctuates between mind-wandering (MW) and on-task (ON) states. MW involves activity within the default-mode network, along with changes in brain rhythms. Recent evidence suggests that these states present on a continuum shaped by awareness […]
RYBREVANT FASPRO™ Receives FDA Approval for First-Line EGFR-Mutated NSCLC
Johnson & Johnson announced that the U.S. Food and Drug Administration (FDA) has approved RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj). It is the first and only subcutaneous treatment for patients who have EGFR-mutated non-small cell lung cancer (NSCLC). This also expands the indications of intravenous (IV) RYBREVANT®. This approval marks a significant advance in patient comfort […]
Beyond the Five: Humans May Have as Many as 33 Senses
We spend much of the day glued to screens, with sight and sound dominating our attention. Yet our other senses are constantly at work, quietly shaping how we experience the world. We feel the textures of objects, notice when our bodies are tense, and sense softness, warmth, or soreness often without conscious awareness. Not a […]
Alcohol Consumption Emerges as a Key Risk Factor for Buccal Cancer in India
Globally, an estimated 400,000 new oral cancer cases were reported during 2022. Oral cancer is the second most common malignancy in India. India reports approximately 79,979 deaths and 143,759 new cases each year. The incidence rate among Indian men is 14.7 per 100,000. Buccal mucosa cancer (BMC) is the most common oral cancer in the […]
Geographic Trends in Antimicrobial Resistance of Enteric Pathogens Causing Travelers’ Diarrhea
Acute travelers’ diarrhea (TD) is one of the most common diseases that affects international travelers, caused by bacterial pathogens like Campylobacter species, Shigella species, nontyphoidal Salmonella (NTS), and diarrheagenic Escherichia coli, causing mild to severe cases. Increasing global antimicrobial resistance specifically to fluoroquinolones and macrolides, which are the basis of empiric therapy, presents a significant […]
Smart Wearables That Detect Frailty Without a Doctor’s Visit
Frailty syndrome is a clinical condition associated with an increased risk of falls, hospitalization, and death, and it is often identified only after a high-risk health event. However, now researchers at the University of Arizona have developed a lightweight wearable that continuously measures frailty during everyday walking using on-device artificial intelligence, with the potential to […]
Exdensur Becomes First Ultra-Long-Acting Biologic Cleared by FDA for Severe Asthma
The U.S. Food and Drug Administration has approved Exdensur (depemokimab-ulaa) as an add-on maintenance therapy for severe asthma with an eosinophilic phenotype in adults as well as adolescents aged ≥12 years. It is manufactured by the GSK Biopharma company. It is the first and only ultra-long-acting biologic for this population, requiring dosing just twice yearly. […]
